These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 29272262)

  • 1. Efficacy and safety of apixaban in real‑life patients at high bleeding risk.
    Bryk AH; Łukaszuk R; Donicz P; Plens K; Undas A
    Pol Arch Intern Med; 2017 Dec; 127(12):889-891. PubMed ID: 29272262
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-activated prothrombin complex concentrates for major bleeding in patients on apixaban and rivaroxaban.
    Sheikh-Taha M
    Intern Emerg Med; 2020 Sep; 15(6):1123-1124. PubMed ID: 31664661
    [No Abstract]   [Full Text] [Related]  

  • 3. Apixaban (Eliquis) in deep vein thrombosis and pulmonary embolism. Warfarin remains the standard therapy.
    Prescrire Int; 2015 Sep; 24(163):206. PubMed ID: 26417627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population Pharmacokinetics, Pharmacodynamics, and Exploratory Exposure-Response Analyses of Apixaban in Subjects Treated for Venous Thromboembolism.
    Byon W; Sweeney K; Frost C; Boyd RA
    CPT Pharmacometrics Syst Pharmacol; 2017 May; 6(5):340-349. PubMed ID: 28547774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effectiveness and safety of apixaban, dabigatran, and rivaroxaban in patients with non-valvular atrial fibrillation.
    Andersson NW; Svanström H; Lund M; Pasternak B; Melbye M
    Int J Cardiol; 2018 Oct; 268():113-119. PubMed ID: 29934230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and effectiveness of rivaroxaban and apixaban in patients with venous thromboembolism: a nationwide study.
    Sindet-Pedersen C; Staerk L; Pallisgaard JL; Gerds TA; Berger JS; Torp-Pedersen C; Gislason GH; Olesen JB
    Eur Heart J Cardiovasc Pharmacother; 2018 Oct; 4(4):220-227. PubMed ID: 29945162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute subdural hematoma in a patient in treatment with apixaban and acetylsalicylic acid].
    Hernández Martín J; Vial Escolano R; Correa Ballester M
    Med Clin (Barc); 2016 Oct; 147(7):e39-40. PubMed ID: 27471015
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy and safety of apixaban compared with aspirin in the elderly: a subgroup analysis from the AVERROES trial.
    Ng KH; Shestakovska O; Connolly SJ; Eikelboom JW; Avezum A; Diaz R; Lanas F; Yusuf S; Hart RG
    Age Ageing; 2016 Jan; 45(1):77-83. PubMed ID: 26590293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apixaban for Treating Venous Thromboembolism in Real-World Clinical Practice.
    Monreal M
    Thromb Haemost; 2018 Nov; 118(11):1850-1851. PubMed ID: 30332697
    [No Abstract]   [Full Text] [Related]  

  • 10. Apixaban for the Treatment of Japanese Subjects With Acute Venous Thromboembolism (AMPLIFY-J Study).
    Nakamura M; Nishikawa M; Komuro I; Kitajima I; Uetsuka Y; Yamagami T; Minamiguchi H; Yoshimatsu R; Tanabe K; Matsuoka N; Kanmuri K; Ogawa H
    Circ J; 2015; 79(6):1230-6. PubMed ID: 25912695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous splenic rupture associated with apixaban.
    López Marcano AJ; de la Plaza Llamas R; Latorre Fragua RA; Medina Velasco AA; Ramia Ángel JM
    Cir Esp (Engl Ed); 2020 Mar; 98(3):164-165. PubMed ID: 31395276
    [No Abstract]   [Full Text] [Related]  

  • 12. Apixaban Auto-intoxication: Toxicokinetics and Coagulation Tests.
    Mast L; Verheul RJ; Reijnen R; van Rossen RCJM; Overdiek JWPM; Wilms EB
    Thromb Haemost; 2017 Nov; 117(11):2209-2211. PubMed ID: 28981556
    [No Abstract]   [Full Text] [Related]  

  • 13. Andexanet alfa-The first 150 days.
    Culbreth SE; Rimsans J; Sylvester K; Pallin DJ; Connors JM
    Am J Hematol; 2019 Jan; 94(1):E21-E24. PubMed ID: 30358896
    [No Abstract]   [Full Text] [Related]  

  • 14. Apixaban and dalteparin in active malignancy associated venous thromboembolism. The ADAM VTE Trial.
    McBane Ii R; Loprinzi CL; Ashrani A; Perez-Botero J; Leon Ferre RA; Henkin S; Lenz CJ; Le-Rademacher JG; Wysokinski WE
    Thromb Haemost; 2017 Oct; 117(10):1952-1961. PubMed ID: 28837207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apixaban versus Warfarin for the Prevention of Periprocedural Cerebral Thromboembolism in Atrial Fibrillation Ablation: Multicenter Prospective Randomized Study.
    Kuwahara T; Abe M; Yamaki M; Fujieda H; Abe Y; Hashimoto K; Ishiba M; Sakai H; Hishikari K; Takigawa M; Okubo K; Takagi K; Tanaka Y; Nakajima J; Takahashi A
    J Cardiovasc Electrophysiol; 2016 May; 27(5):549-54. PubMed ID: 26766541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apixaban to Prevent Venous Thromboembolism in Patients with Cancer.
    Carrier M; Abou-Nassar K; Mallick R; Tagalakis V; Shivakumar S; Schattner A; Kuruvilla P; Hill D; Spadafora S; Marquis K; Trinkaus M; Tomiak A; Lee AYY; Gross PL; Lazo-Langner A; El-Maraghi R; Goss G; Le Gal G; Stewart D; Ramsay T; Rodger M; Witham D; Wells PS;
    N Engl J Med; 2019 Feb; 380(8):711-719. PubMed ID: 30511879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Xa activity in oral factor Xa inhibitor-treated patients with atrial fibrillation and a higher risk of bleeding: a pilot study.
    Samoš M; Bolek T; Stančiaková L; Škorňová I; Bánovčin P; Kovář F; Staško J; Galajda P; Kubisz P; Mokáň M
    Blood Coagul Fibrinolysis; 2018 Jun; 29(4):369-373. PubMed ID: 29538002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apixaban-induced subdural bleeding: case presentation and literature review.
    Alayad E; Khairy S; Aloraidi A
    BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29602894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacologic and clinical characteristics of direct inhibitors of factor Xa: rivaroxaban, apixaban, edoxaban and betrixaban].
    Meddahi S; Samama MM
    J Mal Vasc; 2014 May; 39(3):183-94. PubMed ID: 24650612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are apixaban and rivaroxaban distributed into human breast milk to clinically relevant concentrations?
    Zhao Y; Arya R; Couchman L; Patel JP
    Blood; 2020 Oct; 136(15):1783-1785. PubMed ID: 32488251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.